Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI)
The world’s first university innovation centre specialising in the application of artificial intelligence to accelerate the discovery and development of immunotherapies, vaccines and medical innovation
OUR KEY AREAS
The intersection of AI and medical innovation
BioNTech calls La Trobe home
La Trobe University is home to global biotechnology company BioNTech’s state-of-the-art mRNA clinical-scale manufacturing facility at the Melbourne campus in Bundoora, in an agreement facilitated by the Victorian Government. The facility will support researchers to develop investigational mRNA-based treatment options, as well as manufacture investigational candidates for clinical trials in the Asia-Pacific region.
La Trobe is already a world leader in AI and digital innovation. The Australian Centre for AI in Medical Innovation will greatly accelerate the process of translating medical breakthroughs into cost-effective and widely-accessible, personalised cancer vaccines and treatments.
The planned BioNTech facility will establish La Trobe as a centre of a new mRNA technology, providing access not only to its own researchers but also access to collaborators from across Australia and the world.
IN PARTNERSHIP
ACAMI was established through the support of the Victorian Government through mRNA Victoria.
Connect with us
News
-
Walking football, a win for rural older adults
A pilot study led by researchers at La Trobe University’s Bendigo campus has shown that walking football - a fun, low-impact version of the traditional game - can play a powerful role in improving health.
-
PhD Research Drives AFL Talent Development
Through La Trobe’s Industry PhD program, Lachlan Price is combining cutting-edge sport science research with real-world application.
-
Events
-
AI Disrupting the Workplace
Wednesday 10 September 02:00pm
-
AI at Scale: Industrial Optimisation and Enterprise Defence
Monday 22 September 05:00pm